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 11 
Abstract 12 
AIMS: Visceral artery aneurysms (VAAs), although rare, represent a life-threatening disease with 13 
high mortality rates. With the more frequent use of diagnostic tests, there has been an    incidental 14 
detection of these lesions which are mostly asymptomatic. It follows that surgeons are increasingly 15 
called to decide the most appropriate management of VAAs between an open surgical or 16 
endovascular approach and among the different endovascular options currently available. The aim 17 
of this retrospective study was to evaluate the results of open surgery and interventional 18 
endovascular strategies of visceral artery aneurysms with respect to technical success, therapy-19 
associated complications and post- interventional follow-up in the elective and emergency situation. 20 
METHODS: From January 1992 to January 2017, 125 open surgical or endovascular interventions 21 
for VAA were performed at our institution.  Once the VAA was diagnosed and the indication for 22 
treatment was assessed, the preoperative diagnostic workup consisted of contrast computed 23 
tomography (CT) or magnetic resonance imaging (MR) and, in some patients, digital subtraction 24 
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angiography. Follow-up included clinical and duplex ultrasound scan (DUS) and contrast enhanced 25 
ultrasound (CEUS) to assess the treated vessel patency and organ perfusion after 1, 6, and 12 26 
months, and yearly thereafter. CT or MR controls were also performed at 1 year of follow-up and 27 
only when DUS was not diagnostic or showed a complication thereafter. After the first 5 years of 28 
follow-up, the status of the patient was obtained by a structured telephone survey.  29 
RESULTS: The treatment option was endovascular in 56 out of 125 cases (44.8%). Technical 30 
success was 98.3%. In one case the procedure was interrupted for the extensive dissection of the 31 
afferent vessel. Twenty-six patients were treated by coils embolization while 29 with covered 32 
stenting. The endovascular approach was in emergency in two cases (3.6%). In the endovascular 33 
group, mortality was nil. Complications occurred in 5 cases (8.9%): 1 sub-acute intestinal ischemia 34 
caused by superior mesenteric artery dissection, 2 aneurysm reperfusion, 1 stent thrombosis and 1 35 
massive splenic hematoma. In 69 (55.2%) surgical treatment was preferred, with 24 VAA resections 36 
and 45 arterial reconstructions. In 20 cases (29%), open surgery was performed in emergency 37 
conditions. In the surgical group, 8 emergency patients (40%) died intraoperatively. The mortality 38 
after elective surgical interventions was nil. Complications after surgery were 4 graft late 39 
thrombosis (5.8%): asymptomatic in three cases and requiring splenectomy in one.  40 
CONCLUSIONS: There is no overall consensus regarding the indications for treatment of VAA. 41 
Currently in emergent setting, the endovascular approach should be considered as first choice, 42 
because of its reduced invasiveness, faster way to access and bleeding control; this accounts for the 43 
lower morality of the interventional therapy than open surgery 44 
Endovascular approach is effective for elective repair of VAAs but, procedure-related 45 
complications may occur in a not negligible number of patients.  Given comparable mortality rates 46 
and low procedure-related complication rate, surgical approach still has space in the elective 47 
management of VAAs, especially for aneurysms unsuitable or challenging for the endovascular 48 
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option in patient with low surgical risk. The size, location and morphology of VAAs, systemic or 49 
local comorbidities and specific anatomical situations such as previous abdominal surgery should 50 
dictate treatment choice.   51 
 52 
Keywords: visceral artery aneurysm, open surgery, endovascular aneurysm repair, stenting, 53 
transcatheter embolization 54 
 55 
Introduction 56 
Visceral artery aneurysms (VAAs) represent a pathological condition with high mortality rates that 57 
ranging from 25%-100 because of their high risk of rupture and consequent fatal bleeding. 1 The 58 
VAAs may affect any of the branches of the abdominal aorta, although hepatic and splenic 59 
aneurysms account for 80% of those reported. Regardless of site and etiology, both true and 60 
pseudo-aneurysms VAAs are still rare occurrences with an incidence in autopsy and angiographic 61 
series of 0.01% to 2%.  62 
Greater availability and increased use of advanced imaging technology, including computed 63 
tomography, magnetic resonance, ultrasonography, and arteriography, led to an increased incidental 64 
detection of asymptomatic visceral aneurysms. 2  65 
On account of this, the vascular surgeon must choose when to treat them more frequently, and with 66 
what approach: endovascular techniques (ET) or open surgery (OS). 3,4  67 
This retrospective study analyzes the results of open surgery and interventional therapy of 68 
aneurysms of the visceral artery in the elective and emergency situations. Special attention is paid to 69 
technical success, periprocedural morbidity, and late complications in order to define the current 70 
role of the surgical approach with respect to the endovascular treatment.  71 
 72 
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Methods 73 
From January 1992 to January 2017, 125 patients (74 males and 51 females) with 131 true visceral 74 
arteries aneurysms were considered suitable for treatment. The mean age was 65 years. In 8 cases 75 
out of 125 an association with secondary small VAAs were found, but these were not considered for 76 
correction. In all cases, the preoperative diagnostic workup consisted of duplex color scan, angio-77 
CT and angio-MRI.  The site of aneurismal disease was renal artery (RA) in 45 patients (36%), 78 
splenic artery (SA) in 41 (32.8%), hepatic artery (HA) in 20 (16%), superior mesenteric artery 79 
(SMA) in 10 (8%), celiac trunk (CT) in 5 (4%), pancreatic-duodenal artery (PDA) in 3 (2.4%) and a 80 
distal branch of the left colic artery (LCA) in 1 (0,8%) (Table I).  81 
According with our standard surveillance protocol, follow-up consisted of clinical and duplex 82 
ultrasound scan (DUS) and contrast enhanced ultrasound (CE S) to assess the treated vessel 83 
patency and organ perfusion   after 1, 6, and 12 months, and yearly thereafter. All patients were 84 
submitted to triphasic contrast-enhanced computed tomography (CT) or to Magnetic Resonance 85 
angiography (MR) at 12 months; after the first year, CT or MR controls were repeated when 86 
ultrasounds showed some modifications or in those cases in which DUS and or CEUS were unable 87 
to correctly follow the patients over time. The mean for follow- up using diagnostic imaging 88 
was 3 6  months (range: 18 – 60 months). After the first 5 years of follow-up, the status of the 89 
patient was obtained by a structured telephone survey.  90 
 91 
Outcome Measures 92 
 93 
The complete aneurysm exclusion on completion angiography was considered as technical success.  94 
while the clinical success implied the patency of the involved artery and target organ perfusion 95 
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Mortality and early and late complications were also assessed in both surgical and interventional 96 
groups. 97 
 98 
Statistical analysis 99 
Clinical data of the patients were extracted and entered into a spreadsheet. Overall survival and 100 
freedom from complications were calculated using Kaplan-Meier survival analysis. We applied the 101 
Log-rank test and considered the results to be significant at an alpha level of 0.05. SPSS Version 24 102 
was used for data analysis.   103 
 104 
Results  105 
 106 
The treatment was carried out by an endovascular approach in 56/125 (44.8%) cases and consisted 107 
of embolization using either pushable coils or detachable coils at the discretion of the investigators, 108 
in 26: 5 RA, 18 SA, 1 SMA, 1 PDA, 1 branch LCA (Fig.1 A-B-C).  The remaining 28 patients were 109 
submitted to covered stenting: 10 RA, 7 SA, 4 CT, 5 HA, 2 SMA. A Cardiatis a self-expandable 110 
stent multilayer was implanted in the common hepatic artery and in the SMA to preserve the 111 
pancreatic-duodenal artery and the ileo-colic artery, respectively (Fig. 4). In both patients, stent and 112 
collateral pathways remained patent during follow-up.   113 
 All procedures were performed under local anesthesia. In this endovascular group the 114 
intervention-related mortality was nil and two major complications occurred (3.6%). In one case, 115 
the endovascular treatment for covered stenting failed because of a superior mesenteric artery 116 
dissection with a complete acute thrombosis of the SMA with abdominal ischemia (1.8%). when 117 
attempting to cannulate the aneurysmal pancreaticoduodenal artery. This approach through the 118 
SMA was necessary because of the chronic occlusion of the CT and the tight angle of its origin 119 
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from the main artery. This patient was managed with watchful waiting and medical therapy and the 120 
6-month-CTA control showed a recanalization of the thrombosed segment of SMA. In another case 121 
(1.8%), a large hematoma of the spleen occurred after SA embolization due to an inadequate distal 122 
control of the guidewire that caused an intra-parenchymal hemorrhage. This patient was treated 123 
conservatively and the 6-month DUS control showed the complete disappearance of the hematoma.  124 
Two patients (3.6%) were submitted to emergent endovascular coils embolization for rupture and 125 
hemorrhage due to a splenic aneurysm near-hilum and to a little aneurysm of a branch of the left 126 
colonic artery, respectively. In both cases, the postoperative course was uneventful. 127 
Regarding the late complications, two patients submitted to transcatheter embolization (3.6%) had 128 
aneurysm reperfusion that was successfully retreated. One patient (1.8%) experienced a thrombosis 129 
of a covered stent implanted in the splenic artery after 1 year which required the splenectomy for 130 
massive spleen ischemia with concomitant abscess. No surgical conversion due to endovascular 131 
treatment failure or periprocedural complications was required. 132 
Sixty-nine cases of this series, (55.2%) were submitted to open surgical treatment, mostly in the 133 
first phase of this experience. The surgical approach included ligation of the artery and re- section 134 
of the aneurysm in twenty-four aneurysms, vascular reconstruction and bypass in forty-five cases. 135 
In this last group, a renal auto-transplantation was carried out (Fig 3 A-B-C-D). 136 
Out of 20 cases treated emergently (29%) for active bleeding VAAs, 8 patients (40%) died, all in 137 
shock before the procedure (Tab II). No deaths related to the elective surgical treatment of VAA 138 
occurred perioperatively and during follow-up. 139 
The late complications following open surgery were:  4 graft occlusions (5.8%) which were 140 
asymptomatic in 3 cases and required a splenectomy in 1 patient. 141 
When analyzing these data with the Kaplan Meier curves, 30-day-freedom from complication was 142 
96.45% in the endovascular group (Figure 6) and 100%; while the 36-month freedom from 143 
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complication was 94.6% in the endovascular group and 98.6% in the open group, although these 144 
findings did not reach a statistical significance.   145 
 146 
Discussion 147 
There is no overall consensus regarding the indications for treatment of VAA. Nevertheless, it is 148 
worldwide accepted that indication for VAAs surgical or endovascular intervention are bases on 149 
several factors generally such VAA-related symptoms, a diameter exceeding 2 cm or exhibiting a 150 
rapid growth. The indications to treat can be expanded to include asymptomatic aneurysms 151 
regardless of size in affected women who wish to become pregnant, in childbearing age and in 152 
patients undergoing an orthotopic liver transplantation and VAAs with peripheral locations 153 
(branches of SMA, IMA, HA and RA).  154 
The goal of treatment of VAAs is to exclude the aneurysmal sac from the systemic circulation while 155 
preserving perfusion of the target organ distal blood flow. For  many  years,  open  repair with 156 
aneurysm excision, exclusion and revascularization was   the  treatments of choice,  but  throughout 157 
the  last  decade  endovascular  repair  including  covered stenting and  transcatheter embolization  158 
has become  increasingly used.  In our experience, the choice between surgery and endovascular 159 
intervention has been mainly based on anatomic suitability and patient comorbidities. It has also 160 
been influenced by the site of VAA and its anatomical and morphological characteristics and the 161 
need to occlude large efferent vessels emerging from the aneurysm.   162 
In this study the outcomes of open surgery and interventional treatment are significant different in 163 
emergency compared to   elective setting.   164 
As similarly observed for ruptured abdominal aortic aneurysms5, our experience, although not 165 
substantial, showed the highest perioperative morality of open surgery compared to the 166 
endovascular repair of bleeding VAAs.  The reported mortality rate of surgery for treating actively 167 
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bleeding aneurysms has a mortality rate of 10 – 40 %, because it may be challenging due to 168 
aneurysm location and particular anatomical situations such as previous abdominal surgery, which 169 
can hinder a rapid control of the hemorrhage 6, 7.  170 
Our data are, however, not suitable to achieve a comparative outcome analysis after surgical and 171 
interventional treatment due to the very small number of emergency cases which were treated by 172 
means of interventional techniques. 173 
The great number patients who received an emergent surgical operation can be justify by the higher 174 
incidence of ruptured VAAs among the patients treated conservatively before the advent of the 175 
endovascular option as showed by Hogendoorn.8  176 
There was no procedure-related mortality in both elective interventional and surgical management 177 
of VAAs This is very low in comparison to other series published (1.3%-7%); 9,10 only Pitton et al 178 
11
 presented a mortality comparable to ours. This is likely the result of the exclusion from the open 179 
surgery group of older patients with more comorbidities who were treated endovascularly or with 180 
conservative management, before we started practicing the endovascular approach.  12  181 
Furthermore, since the minimally invasive endovascular techniques may offer an advantage to 182 
conventional open repair in the presence of a hostile environment 13 in the last decade, the 183 
endovascular approach to VAAs has been our first option in the most challenging scene, such as 184 
abdominal sepsis or pancreatic inflammation. 14 185 
Consistently with other studies, endovascular intervention success rate of this series was high 186 
(98.3%); it was lower than open surgical intervention and this may be related to the increasing 187 
tendency to treat intravascularly the most technically challenging cases. 15  188 
Our data suggest, the interventional approach has a not negligible overall complication rate (8.9%). 189 
These data showed good comparability with other studies reporting complication rates up to 190 
10.3%. 16,17  191 
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The complication rate of the endovascular approach was even higher than after open surgery 192 
(6.6%). A more rigorous selection of cases to treat surgically can explain this difference. Another 193 
crucial point for failure after endovascular exclusion may be if the involved artery did have a 194 
suitable anatomy for the endovascular treatment, since the indication to this approach may 195 
sometimes be forced because it is less invasive than conventional surgery.  196 
In addition, when we consider only the late complications, comparison of the 2 therapeutic options 197 
revealed similar incidence rates (5.4% after ET and 6.6% in after OS) while and reintervention rates 198 
(5.4% in ET vs 1.9% in OS) favored the surgical approach. This is analogous to what has been 199 
showed by Hemp and Sabri 18 who showed there is no significant difference regarding morbidity 200 
and mortality between interventional approach and open surgery while there was a significant 201 
reduction in the length of the hospital stay after interventional therapy. 202 
In our single-center study, graft occlusion was always the late complication following open surgery 203 
and caused target organ ischemia requiring reintervention only in one out of four cases.  204 
This lower reintervention rate following open surgery may be due the fact that the graft 205 
thrombosis developed progressively; this allowed time for collateral formation sufficient to prevent 206 
distal ischemia in the prevalence of the cases.  207 
Aneurysm recanalization was the most frequent complication after interventional treatment; in this 208 
study it always occurred after coil embolization.  209 
This raises the question about the choice of the most appropriate endovascular treatment (coil 210 
embolization vs covered stenting). In our experience this choice was influenced by the aneurysm 211 
morphology and the anatomy of the involved vessel. From our data, large saccular aneurysms may 212 
have poor long-term outcomes with coil embolization, as the coils may not be stable within the 213 
aneurysm and carry a higher risk of displacement and migration.  In such cases, a covered stenting 214 
should be preferred when feasible.  However, the development of microcatheter technology and the 215 
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use of microcoils have allowed for the selective catheterization of even small-caliber vessels and 216 
therefore a more targeted embolization. 19  217 
 Detachable coils (eg, Interlock, Boston Scientific, Marlborough, MA) can be used especially in 218 
very tortuous arteries, when the catheter may not be stable in position while pushable Hydrogel 219 
coils (Terumo, Somerset, NJ) have the advantage of being more thrombogenic to achieve 220 
embolization with fewer coils in large VAAS. 221 
In most cases covered stenting preserves the vessel patency with aneurysm exclusion and no risk 222 
of distal ischemia. However, it may be not feasible due to the tortuosity and not enough 223 
length of the involved artery as seen in our experience with renal stenting for stenosis. 20  224 
Additionally, the risk of stent thrombosis or restenosis can be higher in small caliber and more 225 
tortuous vessels.  Anyway, currently, the improvements in the flexibility and adaptability of low-226 
profile guide wires, newer low profile covered stents allow to treat endovascularly the most of cases 227 
in both elective and emergency situations.  228 
The use of stent grafts to treat aneurysms of bifurcation points of the main or first order visceral 229 
rteries may result in   occlusion of some of these branches with subsequent ischemia of the more or 230 
less extensive parenchyma. In this situation an interesting strategy is the exclusion of aneurysms 231 
using the Cardiatis multilayer stent as suggested by previous reports. 21,22  232 
In this series, the use of this device has shown encouraging results in term of long-lasting patency 233 
and collateral pathways preservation; anyway, two cases are not enough to draw definitive 234 
conclusion. 235 
The potential for early and late complications such as aneurysm reperfusion and late thrombosis of 236 
the graft or of the stent requiring reintervention, necessitates a long-term follow-up using a 237 
multimodality approach after both surgical approach and endoluminal treatment. Following   VAA 238 
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embolization, the diagnostic controls should combine contrast-enhanced US with MRI or CT 239 
evaluation because imaging may be hampered by coil- induced artifacts.  23,24  240 
The study is mainly limited by its retrospective nature and and non-use of other endovascular options 241 
(plugs, thrombin injection, and combined techniques). Although these two groups are comparable 242 
for many variables (age, comorbidities, sex, etc.), the patients were treated in two different period: 243 
until the year 2000, all patients of this series were submitted to open surgery and only after having 244 
achieved an adequate experience in all endovascular techniques, this approach was carried out 245 
routinely as shown in figure 5.  However, it is worth noticing that this experience has collected the 246 
largest series of true VAAs in the literature since most studies include only a small number of 247 
patients only a few centers have reported experience with over 30 cases. 24,25  248 
Conclusions 249 
Although this study cannot provide any definitive evidence about the indication and the best 250 
treatment modality, the endovascular approach for VAAs is safe and technically feasible with low 251 
morbidity and less invasiveness than open procedures.  In emergency, it should be considered as 252 
choice treatment because of its significantly lower perioperative mortality and faster way to access 253 
open surgical treatment.  254 
In elective setting, the choice of the best management is dictated almost on patient risks and 255 
anatomy.  Additionally, it depends on the morphology and site of the aneurysm, the length and 256 
tortuosity of the parent artery and the need to prevent target organ ischemia.  257 
The indications to the endovascular option and the choice of its techniques have to be evaluated 258 
carefully to achieve technical success with long-lasting exclusion of the aneurysm and adequate 259 
organ perfusion. Covered stenting seems to show a slightly better efficacy than transcatheter coiling 260 
to prevent VAA reperfusion. The endovascular therapy and its tools continue to evolve, increasing 261 
its applicability for the management of all aneurysms. However, the potential for early and late 262 
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failure of the endoluminal approach such as growth in sac size or leak, which would require 263 
reintervention is not neglectable. Thus, in subjects with a low surgical risk and aneurysm anatomy 264 
unsuitable for the endovascular treatment, open surgery has still a place as it guarantees a definitive 265 
repair with few late complications and reinterventions during follow-up. 266 
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DISTRICT INVOLVED  N° OF PATIENTS (%) 
Renal Artery  45 patients (36%) 
Splenic Artery 41 patients (32,8%) 
Hepatic artery 20 patients (16%) 
Superior Mesenteric Artery  10 patients (8%) 
Celiac Trunk 5 patients (4%) 
Pancreatic-duodenal artery 3 patients (2,4%) 
Distal branch of the left colic artery 1 patient (0,8%) 
 
Table I. Different localization of VAA 
 
 
 
 
 
 
Endovascular 
treatment 
56/125 
Embolization 
 
Covered stent 
 
Failed procedure 
26 
 
29 
 
1 
 
44% 
 
 
0,8% 
 
Surgical treatment 
69/125 
Resection 
 
Vascular reconstruction 
24 
 
45 
 
55,2% 
 
Table II. Different approaches of treatment 
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Total Cohort  
(n=125) 
 
Endovascular 
Treatment (n=56) 
 
Open Surgery 
(n=69) 
 
Aneurysm type 
Affected arteries,: sites 
 
 
Procedures 
 
Technical success 
Major complications 
Thirty-day mortality 
Vessel preservation 
Target organ ischemia 
 
 
 
131 VAA 
45 RA, 41 SA, 20 HA, 10 
SMA, 5 CT, 3 PDA, 1 
LCA 
 
103 elective, 22 
emergency 
92,5% 
9 
8 
101 
2 
 
60 VAA 
15 RA, 25 SA, 5 
HA, 3 SMA, 4 CT, 
1 PDA, 1 LCA 
 
54 elective, 2 
emergency 
98.3% 
5  
0 
56 
2b 
 
71 VAA 
30 RA, 16 SA, 15 
HA, 7 SMA, 1 CT, 2 
PDA 
 
49 elective, 20 
emergency 
94.2% 
4 
8a 
45 
0 
Abbreviations: VAA, visceral artery aneurysm; RA, renal artery; SA, splenic artery; HA, hepatic artery; SMA, superior 
mesenteric artery; CT, celiac trunk; PDA, pancreatic duodenal artery; LCA, left colic artery. 
a 8 Emergency 
b One early, one late complication 
 
Table III. Patients undergoing treatment for Visceral Artery Aneurysms 
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Fig. 1 
 
 
Fig. 2 
 
 
Fig. 3 
 
 
Fig. 4 
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Fig. 5 
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Figure 1. A) Intraoperative angiogram of a pancreatic-duodenal artery aneurysm; B) Coils 
embolization of the PDA aneurysm; C) Final angiogram showing the complete embolization 
of the aneurysm 
 
Figure 2.  A) 3D reconstruction showing a splenic artery aneurysm; B) Intraoperative 
angiogram of the same splenic artery aneurysm; C) Intraoperative angiogram showing a 
covered stent deployment to exclude the aneurysm. 
 
Figure 3. A) Intraoperative angiogram of an pararenal artery aneurysm; B) Intraoperative 
picture of the renal artery aneurism resection; C) Replanting of the two renal arteries on 
Teflon patch; D) Kidney replanting in iliac fossa with anastomosis on external iliac artery and 
vein 
 
Figure 4. A) Preop. angioCT that shows a dissection of the SMA with aneurismal dilatation. 
B-C) Angiographic images of Cardiatis stent deployement D) Control angioCT at 31 months 
that shows clearly a patency of the implanted Cardiatis stent. 
 
Figure 5. Graphic shows different approaches during the period examined. 
 
 
